Shenwan Hongyuan Group (06806) : "25D12" will be redeemed and delisted on June 11th.
Shenwan Hongyuan (06806) announced that its subsidiary Shenwan Hongyuan Securities Co., Ltd. issued the Shenwan Hongyuan Securities Co., Ltd. 2025 series of short-term corporate bonds (first series) for professional investors on October 23, 2025. The issuance size is RMB 6.3 billion, with a maturity of 231 days, a coupon rate of 1.73%, bond code 524482, and bond short name 25ShenD12.
Shenwan Hongyuan Group (06806) announced that its subsidiary, Shenwan Hongyuan Group Securities Co., Ltd., issued the Shenwan Hongyuan Group Securities Co., Ltd. 2025 short-term corporate bonds (first tranche) for professional investors on October 23, 2025. The issuance amount is 6.3 billion yuan, with a maturity of 231 days, a coupon rate of 1.73%, bond code 524482, and bond abbreviation 25 ShenD12.
The redemption date for this bond is June 11, 2026, and the delisting date is also June 11, 2026. Shenwan Hongyuan Group Securities Co., Ltd. has completed the redemption of principal and interest for this bond in accordance with the relevant provisions of the "Shenwan Hongyuan Group Securities Co., Ltd. 2025 Short-term Corporate Bond (First Tranche) Prospectus for Professional Investors" and will delist it.
Related Articles

Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!
Buying low on Shenzhen Hepalink Pharmaceutical Group (09989) for two consecutive months, will the Hong Kong Stock Connect funds soon witness the reversal of the heparin cycle?

New Stock News | Leading supply chain company Andes Zhilian's Hong Kong IPO prospectus updated, achieving double high increase in revenue and net profit.

How strong is the demand for SpaceX (SPCX.US) IPO? Oversubscribed subscriptions, "greenshoe" exemption from commission, and options expected to open next week!

RECOMMEND





